These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26292025)

  • 1. Low-dose arsenic-mediated metabolic shift is associated with activation of Polo-like kinase 1 (Plk1).
    Li Z; Lu Y; Ahmad N; Strebhardt K; Liu X
    Cell Cycle; 2015; 14(19):3030-9. PubMed ID: 26292025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.
    Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C
    Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of rictor as a novel substrate of Polo-like kinase 1.
    Shao T; Liu X
    Cell Cycle; 2015; 14(5):755-60. PubMed ID: 25714006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plk1 inhibition enhances the efficacy of androgen signaling blockade in castration-resistant prostate cancer.
    Zhang Z; Hou X; Shao C; Li J; Cheng JX; Kuang S; Ahmad N; Ratliff T; Liu X
    Cancer Res; 2014 Nov; 74(22):6635-47. PubMed ID: 25252916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin promotes proliferation of pancreatic ductal epithelial cells by increasing expression of PLK1 through PI3K/AKT and NF-κB pathway.
    Wu K; Wang W; Chen H; Gao W; Yu C
    Biochem Biophys Res Commun; 2019 Feb; 509(4):925-930. PubMed ID: 30642632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma.
    Liu TT; Yang KX; Yu J; Cao YY; Ren JS; Hao JJ; Pan BQ; Ma S; Yang LY; Cai Y; Wang MR; Zhang Y
    J Mol Med (Berl); 2018 Aug; 96(8):807-817. PubMed ID: 29959473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plk1 phosphorylation of IRS2 prevents premature mitotic exit via AKT inactivation.
    Chen L; Li Z; Ahmad N; Liu X
    Biochemistry; 2015 Apr; 54(15):2473-80. PubMed ID: 25830382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of p21 with NF-YA suppresses the expression of Polo-like kinase 1 and prevents mitotic death in response to DNA damage.
    Lin YC; Chen YN; Lin KF; Wang FF; Chou TY; Chen MY
    Cell Death Dis; 2014 Jan; 5(1):e987. PubMed ID: 24407240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state.
    Li Z; Li J; Bi P; Lu Y; Burcham G; Elzey BD; Ratliff T; Konieczny SF; Ahmad N; Kuang S; Liu X
    Mol Cell Biol; 2014 Oct; 34(19):3642-61. PubMed ID: 25047839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy.
    Tan J; Li Z; Lee PL; Guan P; Aau MY; Lee ST; Feng M; Lim CZ; Lee EY; Wee ZN; Lim YC; Karuturi RK; Yu Q
    Cancer Discov; 2013 Oct; 3(10):1156-71. PubMed ID: 23887393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulatory effect of curcumin on survival of irradiated human intestinal microvascular endothelial cells: role of Akt/mTOR and NF-{kappa}B.
    Rafiee P; Binion DG; Wellner M; Behmaram B; Floer M; Mitton E; Nie L; Zhang Z; Otterson MF
    Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G865-77. PubMed ID: 20299603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The scaffold protein TANK/I-TRAF inhibits NF-kappaB activation by recruiting polo-like kinase 1.
    Zhang W; Wang J; Zhang Y; Yuan Y; Guan W; Jin C; Chen H; Wang X; Yang X; He F
    Mol Biol Cell; 2010 Jul; 21(14):2500-13. PubMed ID: 20484576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis.
    Gao W; Zhang Y; Luo H; Niu M; Zheng X; Hu W; Cui J; Xue X; Bo Y; Dai F; Lu Y; Yang D; Guo Y; Guo H; Li H; Zhang Y; Yang T; Li L; Zhang L; Hou R; Wen S; An C; Ma T; Jin L; Xu W; Wu Y
    Cell Death Dis; 2020 Oct; 11(10):919. PubMed ID: 33106477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer.
    Shao C; Ahmad N; Hodges K; Kuang S; Ratliff T; Liu X
    J Biol Chem; 2015 Jan; 290(4):2024-33. PubMed ID: 25505174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation.
    Koida N; Ozaki T; Yamamoto H; Ono S; Koda T; Ando K; Okoshi R; Kamijo T; Omura K; Nakagawara A
    J Biol Chem; 2008 Mar; 283(13):8555-63. PubMed ID: 18174154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plk1 phosphorylation of Numb leads to impaired DNA damage response.
    Shao C; Chien SJ; Farah E; Li Z; Ahmad N; Liu X
    Oncogene; 2018 Feb; 37(6):810-820. PubMed ID: 29059161
    [TBL] [Abstract][Full Text] [Related]  

  • 17.  p53 is not directly relevant to the response of Polo-like kinase 1 inhibitors.
    Sanhaji M; Kreis NN; Zimmer B; Berg T; Louwen F; Yuan J
    Cell Cycle; 2012 Feb; 11(3):543-53. PubMed ID: 22262171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.
    Lin YC; Sun SH; Wang FF
    Cell Signal; 2011 Nov; 23(11):1816-23. PubMed ID: 21726628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VS-5584 as a PI3K/mTOR inhibitor enhances apoptotic effects of subtoxic dose arsenic trioxide via inhibition of NF-κB activity in B cell precursor-acute lymphoblastic leukemia.
    Toosi B; Zaker F; Alikarami F; Kazemi A; Teremmahi Ardestanii M
    Biomed Pharmacother; 2018 Jun; 102():428-437. PubMed ID: 29574283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tripping on TRIB3 at the junction of health, metabolic dysfunction and cancer.
    Mondal D; Mathur A; Chandra PK
    Biochimie; 2016 May; 124():34-52. PubMed ID: 26855171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.